Newsletters
181 views

New Cancer Center
Dec. 1 Speaker: Dr. Mark McLaughlin Wellstar N. Fulton


Excited to hear from Dr. Mark McLaughlin about the latest news on WellStar North Fulton's Cancer Center. All of us have been touched by cancer in some manner and we are so fortunate to have this center right here in our community. 

Dr. Mark McLaughlin received his bachelor’s degree in computer science from Duke University and his medical degree from the Medical College of Georgia in Augusta. He completed his surgical internship at Shands Teaching Hospital, College of Medicine at University of Florida, where he also completed his residency in radiation oncology. Dr. McLaughlin also holds a master’s degree in healthcare administration from Central Michigan University.

McLaughlin is board-certified in radiation oncology. In his spare time, he enjoys sports, travel, gardening, boating, martial arts and reading.

Cancer Care at Wellstar

People face cancer with confidence at Wellstar because of our multidisciplinary care model, physicians’ expertise and advanced treatments close to home. In fact, we have more than 300 healthcare providers that provide expert cancer care at convenient locations across Georgia.

WellStar's multidisciplinary teams surround patients and their families with knowledgeable and compassionate support. Specialty programs for patients are led by physicians with advanced training. Here, patients see leading specialists who are experts in their fields.

Wellstar invests in state-of-the-art technology and participates in clinical trials to give patients access to a variety of advanced treatments including minimally-invasive surgery, high precision radiation dosages by CyberKnife and TrueBeam delivery systems, intraoperative radiation therapy (IORT), Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) as well as chemotherapy, immunotherapy, and targeted therapies based on the latest advances in biomarker testing. Patients who qualify for clinical trials have access to groundbreaking treatments, often years before they are FDA-approved.

Because of Wellstar’s integrated approach to cancer treatment, our programs are nationally recognized by The American College of Surgeons (ACS) Commission on Cancer and the Care Continuum Centers of Excellence (CCCOE), a program of the GO2 Foundation for Lung Cancer, among others.
Posted by Susan Rumble
November 29, 2022

Comments

This Year’s Posts: